Pro-resolving lipid mediators are leads for resolution physiology

被引:2099
|
作者
Serhan, Charles N. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
TRIGGERED 15-EPI-LIPOXIN A(4); ACUTE INFLAMMATORY RESPONSES; DOCOSAHEXAENOIC ACID; LIPOXIN A(4); NEUROPROTECTIN D1; PROTECTIN D1; ANTIINFLAMMATORY PROPERTIES; STEREOCHEMICAL ASSIGNMENT; PRORESOLVING MEDIATORS; LEUKOCYTE RECRUITMENT;
D O I
10.1038/nature13479
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Advances in our understanding of the mechanisms that bring about the resolution of acute inflammation have uncovered a new genus of pro-resolving lipid mediators that include the lipoxin, resolvin, protectin and maresin families, collectively called specialized pro-resolving mediators. Synthetic versions of these mediators have potent bioactions when administered in vivo. In animal experiments, the mediators evoke anti-inflammatory and novel pro-resolving mechanisms, and enhance microbial clearance. Although they have been identified in inflammation resolution, specialized pro-resolving mediators are conserved structures that also function in host defence, pain, organ protection and tissue remodelling. This Review covers the mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 50 条
  • [1] Pro-resolving lipid mediators are leads for resolution physiology
    Charles N. Serhan
    [J]. Nature, 2014, 510 : 92 - 101
  • [2] Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases
    Cheng, Yuanyuan
    Rong, Jianhui
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (05) : 423 - 436
  • [3] Specialized pro-resolving lipid mediators and resolution of viral diseases
    Ferri, Giulia
    Mucci, Matteo
    Mattoscio, Domenico
    Recchiuti, Antonio
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2023, 168
  • [4] Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
    Gila-Diaz, Andrea
    Carrillo, Gloria Herranz
    Singh, Pratibha
    Ramiro-Cortijo, David
    [J]. ANTIOXIDANTS, 2021, 10 (06)
  • [5] Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
    Anghelache, Maria
    Voicu, Geanina
    Deleanu, Mariana
    Turtoi, Mihaela
    Safciuc, Florentina
    Anton, Ruxandra
    Boteanu, Delia
    Fenyo, Ioana Madalina
    Manduteanu, Ileana
    Simionescu, Maya
    Calin, Manuela
    [J]. ADVANCED HEALTHCARE MATERIALS, 2024, 13 (03)
  • [6] Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis
    Robinson, Peyton Z.
    Frank, Daniel N.
    Ramakrishnan, Vijay R.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (08) : 969 - 979
  • [7] The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
    Serhan, Charles N.
    Chiang, Nan
    Dalli, Jesmond
    [J]. SEMINARS IN IMMUNOLOGY, 2015, 27 (03) : 200 - 215
  • [8] Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases
    Shang, Pei
    Zhang, Ying
    Ma, Di
    Hao, Yulei
    Wang, Xinyu
    Xin, Meiying
    Zhang, Yunhai
    Zhu, Mingqin
    Feng, Jiachun
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (11) : 967 - 986
  • [9] Pro-resolving lipid mediators in allergic inflammation
    Barnig, C.
    [J]. REVUE FRANCAISE D ALLERGOLOGIE, 2016, 56 (01): : 38 - 42
  • [10] Pro-resolving lipid mediators in vascular disease
    Conte, Michael S.
    Desai, Tejal A.
    Wu, Bian
    Schaller, Melinda
    Werlin, Evan
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (09): : 3727 - 3735